Camelia Hrab

Innovation, tech, entrepreneurship enthusiast. Interested in cancer fighting innovation. Working on #RLT #PSMA . Tweets are my own

[The Lancet Oncology @TheLancetOncol]

Presented at #ESMO24 and published simultaneously @TheLancetOncol: https://t.co/uXiMcKRXAL

The randomised ph2 UpFrontPSMA study:

Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive #prostatecancer

[The Lancet @TheLancet]

Prostate cancer cases are expected to double from 1.4 million per year in 2020 to 2.9 million per year by 2040, new analysis suggests.

More from the Lancet Commission on #ProstateCancer in-thread 🧵

▶️ https://t.co/r1VhQobHKR

[Jay Shetty @jayshetty]

This week on the podcast I sit down with Darshan Shah to discuss the 3 step process to reset your gut health and reduce inflammation & why sitting is increasing your mortality rate by 10%. Full talk right here 👉 https://t.co/2pyHlfQoNc

[Alex Osterwalder🇨🇭 @AlexOsterwalder]

Here's want drives problem-oriented innovators @DavidSchonthal on #InnovaBuzz podcast via @innovabiz https://t.co/TaoKfaFk0r

[Susan David, Ph.D. @SusanDavid_PhD]

When you’ve made a tough decision, don’t spend all your time dwelling on the possibilities of an alternate path. Stay connected to the beauty of the current moment so you don’t miss what you do have by wishing for what you don’t.

[Novartis News @NovartisNews]

Novartis announces the PSMAfore Phase III study met its primary endpoint in metastatic castration-resistant #prostatecancer (mCRPC) – a disease with a high unmet need for targeted treatment options. #NovartisNews #reimaginemedicine https://t.co/g8zgw5CDlw

[Camelia Hrab @CameliaHrab]

Explainer exploring the science behind the exciting #RLT #RLI therapy platform #Oncology

[Novartis @Novartis]

How do we improve our odds of knowing whether a medicine may be right for a cancer patient? One potential strategy may be to shine a light on #cancer … with atomic energy.

Learn about radioligand imaging and therapy.

[Camelia Hrab @CameliaHrab]

Great news on this therapy that so many people worked on for so many years #prostatecancer #RLT #PSMA #proud

[Novartis News @NovartisNews]

Novartis received a positive CHMP opinion about our targeted #radioligandtherapy for more #cancer patients in need #NovartisNews #reimaginingmedicine

[Camelia Hrab @CameliaHrab]

"Why is it that innovations require heroics to occur in our organization?" Great read #Innovation #OrganizationalDesign https://t.co/lu2fLYOTJS by @sgblank

[Camelia Hrab @CameliaHrab]

Really enjoyed this talk with Suku Nagendran speaking about his experience as CMO of former Avexis.
“I’m a nobody who became a somebody because of all the people around me.” #leadership #biotech
https://t.co/AKsQitTSmT

[Camelia Hrab @CameliaHrab]

Hype versus reality: What you can't do with DeepMind's #AlphaFold in drug discovery https://t.co/uWmRkGdxY9 via @theregister

[Camelia Hrab @CameliaHrab]

A memory prosthesis could restore memory in people with damaged #brain. Still some way from clinical use https://t.co/R4WCCIrw2c from @techreview

[Camelia Hrab @CameliaHrab]

Really insightful @a16zpodcast podcast on the the psychology of #decisionmaking. @AnnieDuke covers lots of useful strategies, tools, and mindsets
https://t.co/zLTJKYUNKe

[Camelia Hrab @CameliaHrab]

Heavy toll of #covid on #inequality (via @Nature) https://t.co/PVeseRiWU8

[Camelia Hrab @CameliaHrab]

Humanocracy: How to Create Organizations as Amazing as the People Inside... Best discussion on #leadership and/vs #management I heard in a while https://t.co/mIFNFOpIWd

[Camelia Hrab @CameliaHrab]

Going Beyond “Innovation Theater” with Steve Blank . Exciting discussion between experts. https://t.co/Grcgup0wKS

[ASCO @ASCO]

Real-world use of prostate-specific radioligand therapy: Check out the #ASCO22 Ed Session + #ASCOEdBook article by @DrMHofman, @CalaisJeremie, Dr. David Schuster et al: https://t.co/jYSUm6HZFw #pcsm

[Daniel Castellano @cdanicas]

📌 Opening the #APCCC22 session with an emotional and deep thought about prostate cancer illness by @davidmatheson! Thanks!!👏👏

[Camelia Hrab @CameliaHrab]

Novartis reports positive health-related quality of life data for 177Lu-PSMA-617 radioligand therapy in patients with advanced prostate cancer at ESMO 2021

#ProstateCancer #ESMO21 #RadioLigandTherapy #PSMA #PhenotypicPrecisionMedicine #prostatecancerawareness #PCandPSMA

[Novartis News @NovartisNews]

Novartis is proud to present health-related quality of life data at #ESMO21 for patients with advanced prostate cancer. #NovartisNews

[Urologic Oncology Updates @UroOncologyOk]

Lutetium is changing the landscape of advanced prostate cancer completely. @EurUrolOncol @Uroweb @EurUrolFocus @UroOncologyOk @CleClinicNeph @CleClinicUroRes @morr316 @MUN_journal @SIU_urology @SIU_URO_RES @RSanchez_Salas @MBaptistussi @CAU_URO @cauperu2021 @ResidentesCAU